Drug Type Prophylactic vaccine |
Synonyms Bivalent MenB OMV vaccine Finlay/GlaxoSmithKline |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Meningococcal Infections | Phase 2 | Belgium | - | |
| Meningococcal Infections | Phase 2 | Belgium | - | |
| Meningococcal Infections | Phase 2 | Spain | - | |
| Meningococcal Infections | Phase 2 | Spain | - |





